[Mindray Announces Up to $200 Million Share Repurchase Program Shenzhen, China November 4, 2013 Mindray Medical International Limited (Mindray or Company, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The program is authorized to be in effect starting from today and]
[Mindray Announces Up to $200 Million Share Repurchase Program Shenzhen, China November 4, 2013 Mindray Medical International Limited (Mindray or Company, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The program is authorized to be in effect starting from today and]
[Mindray Announces Third Quarter 2013 Financial Results Shenzhen, China November 4, 2013 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2013. Highlights for Third Quarter 2013 Net revenues increased 15.3% year-over-year to $296.3 million. International]
[Mindray Announces Third Quarter 2013 Financial Results Shenzhen, China November 4, 2013 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2013. Highlights for Third Quarter 2013 Net revenues increased 15.3% year-over-year to $296.3 million. International]
[Mindray Announces Up to $200 Million Share Repurchase Program Shenzhen, China November4, 2013 Mindray Medical International Limited (Mindray ormpany, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The program is authorized to be in effect starting from today]
[Mindray Announces Up to $200 Million Share Repurchase Program Shenzhen, China November4, 2013 Mindray Medical International Limited (Mindray ormpany, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The program is authorized to be in effect starting from today]
[Mindray Announces Third Quarter 2013 Financial Results Shenzhen, China November4, 2013 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September30, 2013. Highlights for Third Quarter 2013 Net revenuesreased 15.3% year-over-year to $296.3 million. Internationalles grew]
[Mindray Announces Third Quarter 2013 Financial Results Shenzhen, China November4, 2013 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September30, 2013. Highlights for Third Quarter 2013 Net revenuesreased 15.3% year-over-year to $296.3 million. Internationalles grew]
[October 31, 2013 Special Committee of the Board of Directors UTStarcom Holdings Corp. Room 303, Building H, Phoenix Place No. A5 Shuguangxili Chaoyang District, Beijing 100028 Peoples Republic of China Dear Sirs: 1 Sincerely, Shah Capital Opportunity Fund LP Himanshu H. Shah Lu Charitable Remainder Trust Lu Family Trust The Lu Family Limited Partnership Hong Liang Lu cc: Colin Banfield,] [Agreement Shah Capital Mr. Shah Lu Trusts Lu Partnership Mr. Lu Party Parties THIS TERMINATION AGREEMENT (this Consortium Agreement WHEREAS, the Parties entered into a consortium agreement dated as of March 27, 2013 (the WHEREAS, the Parties, after consultation with one another, have withdrawn the Proposal (as defined in the Consortium Agreement) and unanimously determined not to proceed]
[Mindray Announces Up to $200 Million Share Repurchase Program Shenzhen, China November4, 2013 Mindray Medical International Limited (Mindray ormpany, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The program is authorized to be in effect starting from today]
